Market Cap2.05B Stock Price34.42 Revenue$0000 View About Agios Pharmaceuticals Agios Pharmaceuticals (NASDAQ: AGIO) operates as a biopharmaceutical company. The company develops therapies for people with rare diseases, particularly focusing on hemolytic and acquired anemias. It aims to provide disease-mo...
AGIO | Complete Agios Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Market Cap* $1.8B Net Profit Margin (2023) XYZ 19.4% (2023 vs 2022) * As of and is in US$ View Agios Pharmaceuticals Inc financials Agios Pharmaceuticals Inc premium industry data and analytics 80+ Lead Sheet Understand when and why to target accounts of prospective leads, as wel...
Get Agios Pharmaceuticals Inc (AGIO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired an interest in Agios Pharmaceuticals’ royalty on Servier’s vorasidenib for $905 million in upfront cash contingent on U.S. Food and Drug Administration (FDA) approval of vo...
Market Cap $2B Current Price $25.00 NASDAQ: AMPH Amphastar Pharmaceuticals Market Cap $2B Current Price $48.02 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. ...